Molecular Partners (MOLN) Stock Chart & Stock Price History $6.06 -0.06 (-0.98%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Molecular Partners Stock Price Performance5 Day Performance-1.52%1 Month Performance+20.65%3 Month Performance-11.13%6 Month Performance+52.17%Year-To-Date Performance+44.89%1 Year Performance+31.09% Receive MOLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. MOLN Stock Chart for Tuesday, November, 5, 2024 MOLN Chart by TradingView Molecular Partners Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$6.12$6.06-0.98%$6.18$5.821,434 shs$222.37 million11/01/2024$5.44$6.12+12.50%$6.24$6.017,813 shs$224.54 million10/31/2024$6.15$5.44-11.54%$6.08$5.3021,433 shs$199.62 million10/30/2024$6.20$6.15-0.81%$6.25$6.086,580 shs$225.59 million10/29/2024$6.46$6.20-4.02%$6.63$6.1119,525 shs$227.43 million10/28/2024$6.49$6.46-0.46%$6.57$6.0538,836 shs$236.97 million Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$6.02$6.49+7.81%$6.90$6.4042,253 shs$238.12 million10/24/2024$5.67$6.02+6.17%$6.24$5.756,340 shs$220.83 million10/23/2024$6.57$5.67-13.70%$6.26$5.5917,984 shs$207.99 million10/22/2024$6.78$6.57-3.10%$7.60$6.24109,890 shs$241.00 million10/21/2024$4.87$6.78+39.22%$7.25$5.87394,301 shs$248.70 million10/18/2024$4.98$4.87-2.21%$5.34$4.8717,413 shs$178.64 million10/17/2024$4.95$4.98+0.61%$4.99$4.912,440 shs$182.68 million10/16/2024$4.95$4.95$4.98$4.706,432 shs$181.58 million10/15/2024$4.86$4.95+1.85%$4.95$4.7121,057 shs$181.58 million10/14/2024$4.75$4.86+2.32%$4.97$4.702,593 shs$178.28 million10/11/2024$4.75$4.75$5.35$4.738,194 shs$174.24 million10/10/2024$5.11$4.75-7.05%$5.35$4.738,194 shs$174.24 million10/09/2024$4.91$5.11+4.15%$5.11$5.11956 shs$187.45 million10/08/2024$4.76$4.91+3.07%$5.35$4.752,239 shs$179.97 million10/07/2024$5.02$4.76-5.18%$5.32$4.4047,698 shs$174.61 million10/04/2024$4.58$5.02+9.61%$5.02$4.60730 shs$184.14 million10/03/2024$4.70$4.58-2.55%$4.75$4.5310,069 shs$168.00 million10/02/2024$4.72$4.70-0.42%$4.77$4.3711,952 shs$172.41 million10/01/2024$5.09$4.72-7.22%$5.00$4.706,340 shs$173.14 million09/30/2024$5.07$5.09+0.34%$5.13$4.7611,133 shs$186.61 million09/27/2024$4.69$5.07+8.10%$5.37$4.7413,379 shs$185.98 million09/26/2024$4.62$4.69+1.52%$5.30$4.648,903 shs$172.04 million09/25/2024$5.02$4.62-7.97%$4.97$4.624,726 shs$169.47 million09/24/2024$4.73$5.02+6.13%$5.02$4.721,953 shs$184.14 million09/23/2024$4.67$4.73+1.28%$4.75$4.446,373 shs$173.51 million09/20/2024$4.67$4.68+0.21%$4.68$4.62137 shs$171.67 million09/19/2024$4.84$4.67-3.51%$4.67$4.462,341 shs$171.31 million09/18/2024$5.08$4.84-4.72%$5.03$4.581,454 shs$177.54 million09/17/2024$5.18$5.08-1.93%$5.20$5.081,754 shs$186.35 million09/16/2024$5.22$5.18-0.77%$5.30$5.18911 shs$190.01 million09/13/2024$5.52$5.22-5.43%$5.33$5.115,424 shs$191.47 million09/12/2024$5.29$5.52+4.35%$5.53$5.52889 shs$202.49 million09/11/2024$5.61$5.29-5.70%$5.62$5.228,521 shs$194.05 million09/10/2024$5.63$5.61-0.36%$6.17$5.2818,923 shs$205.78 millionThis company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry.09/09/2024$5.51$5.63+2.18%$5.72$5.205,326 shs$206.51 million09/06/2024$5.79$5.51-4.75%$6.97$5.2710,268 shs$202.12 million09/05/2024$5.91$5.79-2.15%$5.85$5.79715 shs$212.21 million09/04/2024$5.64$5.91+4.82%$5.91$5.652,783 shs$216.87 million09/03/2024$5.68$5.64-0.70%$5.74$5.644,990 shs$206.89 million09/02/2024$5.68$5.68$6.29$5.5610,300 shs$208.35 million08/30/2024$6.37$5.68-10.83%$6.29$5.5610,373 shs$208.35 million08/29/2024$6.33$6.37+0.63%$6.48$6.011,607 shs$233.66 million08/28/2024$6.92$6.33-8.53%$6.50$6.133,710 shs$232.20 million08/27/2024$6.30$6.92+9.84%$6.92$6.355,608 shs$253.84 million08/26/2024$6.23$6.30+1.12%$6.30$5.984,207 shs$231.10 million08/23/2024$6.70$6.23-7.01%$7.41$6.1012,704 shs$228.53 million08/22/2024$6.32$6.70+6.01%$6.86$6.521,505 shs$245.77 million08/21/2024$6.38$6.32-0.86%$6.40$6.321,971 shs$231.83 million08/20/2024$6.49$6.38-1.77%$6.38$6.38879 shs$233.85 million08/19/2024$6.43$6.49+0.93%$6.49$6.004,465 shs$238.07 million08/16/2024$6.33$6.43+1.63%$6.44$6.191,742 shs$235.87 million08/15/2024$6.20$6.33+2.05%$6.37$6.171,869 shs$232.08 million08/14/2024$6.38$6.20-2.82%$6.48$6.162,236 shs$227.43 million08/13/2024$6.15$6.38+3.74%$6.50$5.946,782 shs$234.03 million08/12/2024$6.04$6.15+1.74%$6.15$6.064,076 shs$225.59 million08/09/2024$6.16$6.04-1.95%$6.25$5.867,571 shs$221.56 million08/08/2024$6.05$6.16+1.82%$6.40$5.846,079 shs$225.96 million08/07/2024$6.17$6.05-1.94%$6.41$6.058,454 shs$221.93 million08/06/2024$6.01$6.17+2.66%$6.45$5.931,976 shs$226.33 million08/05/2024$6.82$6.01-11.81%$6.40$5.755,228 shs$220.46 million Related Companies Kodiak Sciences Stock Chart Adaptimmune Therapeutics Stock Chart Adverum Biotechnologies Stock Chart Karyopharm Therapeutics Stock Chart Omega Therapeutics Stock Chart LianBio Stock Chart BioXcel Therapeutics Stock Chart Renalytix Stock Chart REGENXBIO Stock Chart Pliant Therapeutics Stock Chart Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MOLN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.